Biosimilar Medicines Reading List | Medicines for Europe

From disruption to care for cancer patients 5 September 2022 Biosimilar medicines are biologic medicines that can be used safely…
EMA/HMA share definitive EU-wide position on biosimilar… 19 September 2022 The Biosimilar medicines group, a Medicines for Europe sector group,…
Interview: Medicines for Europe Reports on EU Biosimilar… 27 July 2020 The Center for Biosimilars® (CfB) spoke with Adrian van den Hoven,…
Biosimilar Uptake in Europe: Big Challenges; Bigger Rewards 16 January 2020 Since the first treatment was approved in 2006, Europe has…